Diagnosing and managing polymyalgia rheumatica and temporal arteritis

BMJ

Volumn 315, Issue 7107, 1997, Pages 549-

  Sudlow, Cathie ^a   Finlay, Robin ^b   Freeman, Anthony G ^c   Roome, Paul ^d   Hodgkins, Peter ^e   Hull, Richard ^f  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL UNITED HOSPITAL   (United Kingdom)

^c Meadow Rise   (United Kingdom)

^d Warders Medical Centre   (United Kingdom)

^e UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^f QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; GIANT CELL ARTERITIS; HUMAN; NOTE; PATHOLOGY; RHEUMATIC POLYMYALGIA; SENSITIVITY AND SPECIFICITY;

BIOPSY; GIANT CELL ARTERITIS; HUMANS; POLYMYALGIA RHEUMATICA; SENSITIVITY AND SPECIFICITY;

EID: 0001106886     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.315.7107.549     Document Type: Letter

References (20)

1. Swannell AJ. Polymyalgia rheumatica and temporal arteritis: diagnosis and management BMJ 1997; 314: 1329–32. (3 May.)
2. Pountain G, Hazleman B. Polymyalgia rheumatica and giant cell arteritis. BMJ 1995; 310: 1057–1059.
3. Hall S, Lie JT, Kurland LT, Persellin S, O'Brien PC, Hunder GG. The therapeutic impact of temporal artery biopsy. Lancet 1983; 2:1217–20.
4. Allison MC, Gallagher PJ. Temporal artery biopsy and corticosteroid treatment. Ann Rheum Dis 1984; 43: 416–417.
5. Vilaseca J, Gonzalez A, Cid MC, Lopez-Vivancos J, Ortega A. Clinical usefulness of temporal artery biopsy Ann Rheum Dis 1987; 46: 282–285.
6. Swannell AJ. Polymyalgia rheumatica and temporal arteritis: diagnosis and management BMJ 1997; 314: 1329–32. (3 May.)
7. Dixon AStJ, Beardwell A, Kay A, Wanka J, Wong YT. Polymyalgia and temporal arteritis Ann Rheum Dis 1966; 25: 203–208.
8. Swannell AJ. Polymyalgia rheumatica and temporal arteritis: diagnosis and management BMJ 1997; 314: 1329–32. (3 May.)
9. Freeman AG. Diagnosis and management of arteritis. J R Soc Med 1995; 88: 238–239.
10. Karanjia ND, Cawthorn SJ, Giddings AEB. The diagnosis and management of arteritis. J R Soc Med 1993; 86: 267–270.
11. Freeman AG. Is the erythrocyte sedimentation rate outdated? J R Soc Med 1997; 90: 179–180.
12. Freeman AG. Monitoring the acute phase response. BMJ 1989; 298: 50–51.
13. Swannell AJ. Polymyalgia rheumatica and temporal arteritis: diagnosis and management BMJ 1997; 314: 1329–32. (3 May.)
14. Anonymous. The management of polymyalgia rheumatica and giant cell arteritis. Drug Ther Bull 1993; 31: 65–68.
15. Kyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 1989; 48: 667–671.
16. Kyle V, Hazleman BL. Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. Ann Rheum Dis 1989; 48: 662–666.
17. Swannell AJ. Polymyalgia rheumatica and temporal arteritis: diagnosis and management. BMJ 1997; 314: 1329–1332.
18. Hodgkins PR, Hull RG, Vakalis A, Cole A, Hallet C, Evans AR, et al. Long term oral corticosteroids and osteoporosis prevention in an ophthalmology clinic. Eye 1997; 11: 126–127.
19. Hodgkins PR, Hull RG, Evans AR, Jeffrey MN. Osteoporosis: a survey of consultant ophthalmologists. Br J Ophthalmol 1997; 81: 260.
20. Chief Medical Officer's Advisory Group. Osteoporosis. London: Department of Health, 1994.